Invention Application
- Patent Title: Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
-
Application No.: US18819527Application Date: 2024-08-29
-
Publication No.: US20250127795A1Publication Date: 2025-04-24
- Inventor: Daniel Christopher Brookings , Teresa De Haro Garcia , Yann Foricher , Helen Tracey Horsley , Martin Clive Hutchings , James Andrew Johnson , Malcolm Maccoss , Mengyang Xuan , Zhaoning Zhu
- Applicant: UCB Biopharma SRL , Sanofi
- Applicant Address: BE Brussels; FR Paris
- Assignee: UCB Biopharma SRL,Sanofi
- Current Assignee: UCB Biopharma SRL,Sanofi
- Current Assignee Address: BE Brussels; FR Paris
- Priority: EP17168027 20170425
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D487/18

Abstract:
A compound of formula (I) as defined herein, or a pharmaceutically acceptable salt thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
Public/Granted literature
- US1707983A Gas stove Public/Granted day:1929-04-09
Information query